Cargando…
Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy?
With the sudden outbreak of COVID-19 patient worldwide and associated mortality, it is critical to come up with an effective treatment against SARS-CoV-2. Studies suggest that mortality due to COVID 19 is mainly attributed to the hyper inflammatory response leading to cytokine storm and ARDS in infe...
Autores principales: | Naz, Farha, Arish, Mohd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326128/ https://www.ncbi.nlm.nih.gov/pubmed/32670273 http://dx.doi.org/10.3389/fimmu.2020.01102 |
Ejemplares similares
-
Sphingosine-1-phosphate receptors 2 and 3 reprogram resting human macrophages into M1 phenotype following mycobacteria infection
por: Arish, Mohd, et al.
Publicado: (2022) -
Sphingosine-1-phosphate signaling in Leishmania donovani infection in macrophages
por: Arish, Mohd, et al.
Publicado: (2018) -
Personalized therapy: can it tame the COVID-19 monster?
por: Arish, Mohd, et al.
Publicado: (2021) -
Sphingosine 1-Phosphate: A Novel Target for Lung Disorders
por: Mohammed, Sabira, et al.
Publicado: (2017) -
Corrigendum: Sphingosine 1-Phosphate: A Novel Target for Lung Disorders
por: Mohammed, Sabira, et al.
Publicado: (2018)